Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.56B | 4.28B | 4.20B | 3.37B | 2.98B | 3.62B | Gross Profit |
1.19B | 1.15B | 1.17B | 955.50M | 765.00M | 1.08B | EBIT |
591.00M | -185.40M | 474.00M | 284.20M | 48.40M | 537.10M | EBITDA |
331.10M | 117.70M | 747.00M | 548.10M | 351.00M | 815.90M | Net Income Common Stockholders |
-231.30M | -304.00M | 222.70M | 141.70M | -47.20M | 311.40M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
160.10M | 160.10M | 217.60M | 346.10M | 926.10M | 946.50M | Total Assets |
9.83B | 9.83B | 10.44B | 9.58B | 8.75B | 8.48B | Total Debt |
3.15B | 3.07B | 3.25B | 3.05B | 2.35B | 3.31B | Net Debt |
2.99B | 2.91B | 3.03B | 2.70B | 1.43B | 2.37B | Total Liabilities |
5.53B | 5.53B | 5.85B | 5.49B | 5.54B | 5.91B | Stockholders Equity |
4.22B | 4.22B | 4.51B | 4.01B | 3.14B | 2.49B |
Cash Flow | Free Cash Flow | ||||
355.00M | 126.30M | -16.90M | 55.40M | 203.00M | 161.10M | Operating Cash Flow |
795.80M | 566.90M | 408.40M | 418.20M | 366.60M | 545.10M | Investing Cash Flow |
-468.30M | -215.40M | -400.70M | -2.24B | -343.40M | -495.90M | Financing Cash Flow |
-163.30M | -395.30M | -152.60M | 1.26B | -21.30M | 443.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$8.53B | 29.40 | 8.87% | ― | ― | ― | ||
80 Outperform | C$3.63B | 36.41 | 8.54% | ― | 49.98% | 108.76% | |
66 Neutral | $4.51B | 12.29 | 5.40% | 248.53% | 4.14% | -12.41% | |
$7.21B | 26.62 | ― | ― | ― | |||
78 Outperform | C$978.78M | 24.47 | 5.12% | 0.58% | 8.59% | 242.80% | |
75 Outperform | C$281.94M | 20.89 | 17.82% | ― | 15.25% | 48.96% | |
69 Neutral | C$9.86B | 26.15 | -23.10% | ― | 16.31% | 4.12% |